Back to results

CompletedPhase 1

A Study of LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy Participants

NCT04451408

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Altasciences Clinical Los Angeles, Inc

Cypress, California, United States

+12 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2020-07-07
Enrollment: 139 participants
Sponsor: Eli Lilly and Company
Purpose: basic science

Locations (13)

Altasciences Clinical Los Angeles, IncCypress, California, United States
Collaborative Neuroscience Research, LLCLong Beach, California, United States
Accel Research Sites- Clinical Research UnitDeLand, Florida, United States
MD ClinicalHallandale, Florida, United States
IMIC, Inc.Miami, Florida, United States
Ppd DevelopmentOrlando, Florida, United States
Progressive Medical ResearchPort Orange, Florida, United States
Charter ResearchThe Villages, Florida, United States
Synexus Clinical Research US, Inc.The Villages, Florida, United States
Covance DallasDallas, Texas, United States
Oita University HospitalYufu, Oita Prefecture, Japan
The University of Tokyo HospitalBunkyo-ku, Tokyo, Japan
Clinical Research Hospital TokyoShinjuku-ku, Tokyo, Japan

A Study of LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy Participants — TrialFind